JNGLX
Price
$83.37
Change
+$0.60 (+0.72%)
Updated
Dec 3 closing price
Net Assets
4.95B
LHCAX
Price
$22.84
Change
+$0.07 (+0.31%)
Updated
Dec 3 closing price
Net Assets
8.99M
Interact to see
Advertisement

JNGLX vs LHCAX

Header iconJNGLX vs LHCAX Comparison
Open Charts JNGLX vs LHCAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$83.37
Change+$0.60 (+0.72%)
VolumeN/A
Net Assets4.95B
Lord Abbett Health Care A
Price$22.84
Change+$0.07 (+0.31%)
VolumeN/A
Net Assets8.99M
JNGLX vs LHCAX Comparison Chart in %
View a ticker or compare two or three
VS
JNGLX vs. LHCAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Hold and LHCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.95B vs. LHCAX (8.99M). JNGLX pays higher dividends than LHCAX: JNGLX (0.28) vs LHCAX (0.00). JNGLX was incepted earlier than LHCAX: JNGLX (27 years) vs LHCAX (6 years). LHCAX (3.34) is less costly to investors than JNGLX (0.80). LHCAX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCAX has a lower initial minimum investment than JNGLX: LHCAX (1500) vs JNGLX (2500). LHCAX annual gain was more profitable for investors over the last year : 11.09 vs. JNGLX (8.87). LHCAX return over 5 years is better than : 22.05 vs. JNGLX (14.98).
JNGLXLHCAXJNGLX / LHCAX
Total Expense Ratio0.801.0378%
Annual Report Gross Expense Ratio0.803.3424%
Fund Existence27 years6 years-
Gain YTD22.80219.207119%
Front LoadN/A6%-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.95B8.99M55,044%
Annual Yield % from dividends0.280.00-
Returns for 1 year8.8711.0980%
Returns for 3 years22.3427.7680%
Returns for 5 years14.9822.0568%
Returns for 10 years53.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.440.03
+2.13%
Inhibikase Therapeutics
MMA1.220.02
+1.67%
Mixed Martial Arts Group Limited
CLS308.414.12
+1.35%
Celestica
CRC47.740.31
+0.65%
California Resources Corp
DAWN8.31-0.12
-1.42%
Day One Biopharmaceuticals